Clinical Trial Update: A Study of Adalimumab in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis [Phase 3]

View source ↗

Summary

This update reports results from a Phase 3 study of adalimumab in Japanese patients with moderately to severely active ulcerative colitis, with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Ulcerative Colitis | Phase 3 | Status: COMPLETED | Results posted: 2012-11-27